Catalent’s Biologics Manufacturing Facility Expansion, Bloomington, Indiana, US
Catalent announced plans to expand its biologics manufacturing facility in Bloomington, Indiana, US
Focus:
Catalent announced plans to expand its biologics manufacturing facility in Bloomington, Indiana, US
The Huntsman Cancer Institute (HCI) is a part of the University of Utah campus in...
Read More...
Hanmi Pharmaceutical is constructing a new biologics manufacturing facility in the city of Pyeongtaek in...
Read More...
Pharmaceutical company based in Portugal Hovione is carrying out an expansion of its active pharmaceutical...
Read More...
The University of California, San Diego (UCSD) opened a health sciences biomedical research facility in...
Read More...
Switzerland-based pharmaceutical ingredient manufacturer Helsinn expanded its Biasca site in Switzerland with a new cytotoxic...
Read More...
H3 Biomedicine, the American subsidiary of Tokyo-based company Eisai, opened its new research facility in...
Read More...
Halo Pharmaceuticals' Whippany facility is a cGMP compliant pharmaceutical manufacturing and packaging plant. The faci
Read More...
Haupt Pharma is one of the world's largest contract manufacturers of pharmaceuticals. With nine production...
Read More...
Contract manufacturer hameln pharma's sterile production facility at Hameln, Germany was built to enhance the...
Read More...
Hermes Pharma GmbH has developed and produced compounds at its Wolfsberg plant in Austria since...
Read More...